The impact of public-private partnerships addressing access to pharmaceuticals

Region: Africa; South Asia
Country: -
Client: Initiative on Public-Private Partnerships for Health (IPPPH)
Date: 2004

HLSP conducted a comprehensive assessment of the health and health systems impact of public-private partnerships (PPPs) for improving access to pharmaceuticals in low and middle income countries, through long-term drug donation or discounted pricing agreements by research-based pharmaceutical companies. The review includes studies of drug access programmes in Uganda, Botswana, Sri Lanka and Zambia.

Synthesis Report: Impact of Public-Private Partnerships Addressing Access to Pharmaceuticals in Selected Low and Middle Income Countries

Country studies: Botswana; Sri Lanka; Uganda; Zambia.

Technical area:

• Access to medicines
• Private sector